Keros Therapeutics (KROS) Revenue (2019 - 2025)
Keros Therapeutics (KROS) posted Revenue of $188000.0 for Q4 2025, down 98.67% on a QoQ basis from $14.1 million in Q3 2025, and down 93.82% year-over-year from $3.0 million in Q4 2024.
Keros Therapeutics (KROS) Revenue (2019 - 2025) Analysis & Trends
Keros Therapeutics' Revenue history runs 6 years deep, the most recent figure standing at $188000.0 for Q4 2025.
- Quarterly Revenue fell 93.82% year-over-year to $188000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $243.7 million (up 6837.83% YoY) and the FY2025 annual result came in at $243.9 million, up 6769.41% from the prior year.
- Revenue was $188000.0 for Q4 2025 at Keros Therapeutics, down from $14.1 million in the prior quarter.
- Across five years, Revenue topped out at $211.2 million in Q1 2025 and bottomed at $8000.0 in Q3 2023.
- A 5-year average of $23.6 million and a median of $1.7 million in 2024 frame the typical range for Revenue.
- Peak annual rise in Revenue reached 254413.25% in 2025, while the deepest fall reached 93.82% in 2025.
- Keros Therapeutics' Revenue stood at $17.9 million in 2021, then rose by 0.56% to $18.0 million in 2022, then plunged by 99.21% to $143000.0 in 2023, then soared by 2027.27% to $3.0 million in 2024, then slumped by 93.82% to $188000.0 in 2025.
- Business Quant data shows KROS's Revenue at $188000.0 in Q4 2025, $14.1 million in Q3 2025, and $18.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - | 188,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 188,000.00 |
| Sep 30, 2025 | 14.12 Mn |
| Jun 30, 2025 | 18.17 Mn |
| Mar 31, 2025 | 211.25 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 388,000.00 |
| Mar 31, 2024 | 83,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 17.90 Mn |
| Jun 30, 2021 | 100,000.00 |
| Dec 31, 2019 | 2.50 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 2.50 Mn |
| Mar 31, 2019 | 2.50 Mn |